Skip to content

PHARMACIE NAIM: what changed

BE 0432.596.739NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€16,289
2024 · -€1,775-€14,515
Equity
€189,212
2024 · €205,501-€16,289
Cash
€34,934
2024 · €74,185-€39,251
Balance sheet total
€403,450
2024 · €305,971+€97,479

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€161,222

    up €161,222 (+182%), from €88,656 to €249,878

    of which Other amounts receivable: +€165,846

  • Cash -€39,251

    down €39,251 (-52.9%), from €74,185 to €34,934

    mainly Receivables within one year (-€161,222) and Net result for the year (-€16,289)

  • Tangible fixed assets -€17,393

    down €17,393 (-20.4%), from €85,172 to €67,779

  • Stocks and contracts -€4,531

    down €4,531 (-9.6%), from €47,367 to €42,836

Equity and liabilities
  • Debts after one year +€105,710

    up €105,710 (+314%), from €33,643 to €139,353

  • Profit (loss) carried forward -€16,289

    down €16,289 (-38.9%), from -€41,856 to -€58,146

  • Current portion of long-term debt +€13,543

    up €13,543 (+82.1%), from €16,505 to €30,047

Income statement
  • Staff costs +€17,774

    up €17,774 (+45.1%), from €39,411 to €57,185

  • Gross operating margin +€6,202

    up €6,202 (+10.3%), from €60,276 to €66,478

  • Financial charges +€3,077

    up €3,077 (+99.7%), from €3,085 to €6,162

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 -€1,775
Gross operating margin +€6,202
Staff costs -€17,774
Depreciation +€449
Other operating charges -€252
Financial income -€62
Financial charges -€3,077
Result 2025 -€16,289
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€158,504
Investment €0
Financing +€119,253
Cash 2024 €74,185
Net result for the year -€16,289
Depreciation +€17,393
Stocks and contracts +€4,531
Receivables within one year -€161,222
Deferred charges and accrued income +€2,568
Trade debts -€2,377
Tax, wage and social debts -€1,804
Other debts -€376
Accrued charges and deferred income -€927
Debts after one year +€105,710
Current portion of long-term debt +€13,543
Cash 2025 €34,934
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €305,971 €403,450 +€97,479 +31.9%
Fixed assets 21/28 €85,172 €67,779 -€17,393 -20.4%
Tangible fixed assets 22/27 €85,172 €67,779 -€17,393 -20.4%
Land and buildings 22 €43,780 €38,055 -€5,725 -13.1%
Plant, machinery and equipment 23 €27,437 €23,119 -€4,317 -15.7%
Furniture and vehicles 24 €13,955 €6,605 -€7,350 -52.7%
Current assets 29/58 €220,799 €335,671 +€114,872 +52.0%
Stocks and contracts in progress 3 €47,367 €42,836 -€4,531 -9.6%
Stocks 30/36 €47,367 €42,836 -€4,531 -9.6%
Amounts receivable within one year 40/41 €88,656 €249,878 +€161,222 +182%
Trade receivables 40 €70,444 €65,820 -€4,624 -6.6%
Other amounts receivable 41 €18,212 €184,058 +€165,846 +911%
Cash at bank and in hand 54/58 €74,185 €34,934 -€39,251 -52.9%
Deferred charges and accrued income 490/1 €10,592 €8,023 -€2,568 -24.2%
Total equity and liabilities 10/49 €305,971 €403,450 +€97,479 +31.9%
Equity 10/15 €205,501 €189,212 -€16,289 -7.9%
Contributions 10/11 €55,776 €55,776 = 0.0%
Reserves 13 €191,582 €191,582 = 0.0%
Distributable reserves 133 €191,582 €191,582 = 0.0%
Profit (loss) carried forward 14 -€41,856 -€58,146 -€16,289 -38.9%
Amounts payable 17/49 €100,469 €214,238 +€113,768 +113%
Amounts payable after more than one year 17 €33,643 €139,353 +€105,710 +314%
Financial debts 170/4 €33,643 €139,353 +€105,710 +314%
Amounts payable within one year 42/48 €65,475 €74,461 +€8,986 +13.7%
Current portion of amounts payable after more than one year 42 €16,505 €30,047 +€13,543 +82.1%
Trade debts 44 €41,247 €38,870 -€2,377 -5.8%
Suppliers 440/4 €41,247 €38,870 -€2,377 -5.8%
Taxes, remuneration and social security 45 €7,347 €5,543 -€1,804 -24.6%
Taxes 450/3 - €103 +€103
Remuneration and social security 454/9 €7,347 €5,441 -€1,906 -25.9%
Other amounts payable 47/48 €376 €0 -€376 -100%
Accrued charges and deferred income 492/3 €1,352 €424 -€927 -68.6%
Remuneration, social security and pensions 62 €39,411 €57,185 +€17,774 +45.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €17,842 €17,393 -€449 -2.5%
Other operating charges 640/8 €1,968 €2,221 +€252 +12.8%
Gross operating margin 9900 €60,276 €66,478 +€6,202 +10.3%
Operating profit (loss) 9901 €1,054 -€10,322 -€11,376
Financial income 75/76B €257 €194 -€62 -24.2%
Recurring financial income 75 €257 €194 -€62 -24.2%
Financial charges 65/66B €3,085 €6,162 +€3,077 +99.7%
Recurring financial charges 65 €3,085 €6,162 +€3,077 +99.7%
Profit (loss) for the period before taxes 9903 -€1,775 -€16,289 -€14,515 -818%
Income taxes 67/77 €0 - =
Profit (loss) for the period 9904 -€1,775 -€16,289 -€14,515 -818%
Profit (loss) for the period to be appropriated 9905 -€1,775 -€16,289 -€14,515 -818%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€189,212 to €189,212

Midpoint €189,212 · adjusted equity only

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €189,212
Indication €189,212

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€189,212
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€189,212

Capitalised earnings

net result for the year (9904)
2025
-€16,289
2024
-€1,775
2023
-€38,200
2022
-€1,881
2021
€9,323
Average result
-€18,755
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.